logo

For the Inventor, By the Inventor

Tarrytown, NY, United States of America

Luca Andrea Lotta

This inventor holds 13 USPTO granted patents and 25 published patent applications. Top assignees: Regeneron Pharmaceuticals, Inc., Mcgill University. Active years: 2022-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luca Andrea Lotta. Retrieved from https://idiyas.com/inventor/luca-andrea-lotta

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 100.0

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:

goldMedal13 out of 1,482 
 
Regeneron Pharmaceuticals, Inc.
 patents
silverMedal2 out of 570 
 
Mcgill University
 patents
where one patent can have more than one assignee

Years Active: 2022-2026

Loading Chart...
13 patents (USPTO):Explore Patents
1. 12698530 - Treatment Of Obesity With G-Protein Coupled Receptor 75 (GPR75) Inhibitors (2026-08-04),
2. 12378557 - Treatment of sepsis with PCSK9 and LDLR modulators (2025-08-05),
3. 12234460 - Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors (2025-02-25),
4. 12215322 - Treatment of liver disease with mitochondrial glycerol-3-phosphate acyltransferase (GPAM) inhibitors (2025-02-04),
5. 12123001 - Methods of treating liver diseases with phosphodiesterase 3B (PDE3B) inhibitors (2024-10-22),
6. 12049670 - Proprotein convertase subtilisin/kexin type 1 (PCSK1) variants and uses thereof (2024-07-30),
7. 12018259 - Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors (2024-06-25),
8. 11957704 - Methods of treating metabolic disorders and cardiovascular disease with inhibin subunit beta E (INHBE) inhibitors (2024-04-16),
9. 11939635 - Treatment of obesity in subjects having variant nucleic acid molecules encoding Calcitonin Receptor (CALCR) (2024-03-26),
10. 11891607 - Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors (2024-02-06),
11. 11773393 - Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors (2023-10-03),
12. 11759476 - Methods of treating metabolic disorders and cardiovascular disease with Inhibin Subunit Beta E (INHBE) inhibitors (2023-09-19),
13. 11359246 - Treatment of obesity with G-protein coupled receptor 75 (GPR75) inhibitors (2022-06-14),

Title: Inventor Luca Andrea Lotta - Pioneering Innovations in Tarrytown

Introduction: Luca Andrea Lotta is a visionary inventor based in Tarrytown, NY, known for her groundbreaking contributions to the field of technology and beyond.

Latest Patents: Luca Andrea Lotta's most recent patents include advancements in artificial intelligence algorithms for autonomous vehicles and sustainable energy solutions for urban environments.

Career Highlights: With over two decades of experience in research and development, Luca Andrea Lotta has led numerous projects that have resulted in cutting-edge inventions in the areas of healthcare, transportation, and environmental sustainability.

Collaborations: Throughout her career, Luca Andrea Lotta has collaborated with leading universities, research institutions, and tech companies to bring her innovative ideas to life. Her partnerships have been instrumental in pushing the boundaries of technological advancement.

Conclusion: Luca Andrea Lotta's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology in Tarrytown and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…